Scope
Reference
C362396
Description
NHS Blood and Transplant (NHSBT) are seeking a provider for Next Generation Sequencing (NGS) QC testing requirements for the Cellular and Molecular Therapies (CMT) directorate, namely the Clinical Biotechnology Centre (CBC). CBC handle a number of products in the production of Advanced Therapeutic Investigational Medicinal Products (ATMPs) and starter material master cell banks (MCBs). These require NGS QC testing services that meet specific regulatory requirements.
Total value (estimated)
- £600,000 excluding VAT
- £660,000 including VAT
Above the relevant threshold
Contract dates (estimated)
- 1 April 2026 to 31 March 2027
- Possible extension to 31 March 2028
- 2 years
Description of possible extension:
One (1) year optional extension
Options
The right to additional purchases while the contract is valid.
One (1) year optional extension
Main procurement category
Services
CPV classifications
- 72225000 - System quality assurance assessment and review services
Contract locations
- UKK11 - Bristol, City of
Participation
Legal and financial capacity conditions of participation
As detailed in tender documents ( https://atamis-1928.my.site.com/ - C362396
Technical ability conditions of participation
As detailed in tender documents ( https://atamis-1928.my.site.com/ - C362396. Must be EU Good Manufacturing Practice (GMP) Licenced.
Particular suitability
Small and medium-sized enterprises (SME)
Submission
Enquiry deadline
29 January 2026, 12:00pm
Submission type
Tenders
Tender submission deadline
9 February 2026, 12:00pm
Submission address and any special instructions
Tenders may be submitted electronically
Yes
Languages that may be used for submission
English
Award decision date (estimated)
30 March 2026
Award criteria
| Name | Type | Weighting |
|---|---|---|
| Price | Price | 60.00% |
| Quality | Quality | 30.00% |
| Social Value | Quality | 10.00% |
Other information
Payment terms
30 days
Description of risks to contract performance
Regulatory Changes: Future amendments to applicable laws, regulations, or industry standards may require adjustments to processes, compliance obligations, or service delivery models. Such changes could necessitate contract modifications to ensure continued compliance and operational effectiveness.
Authority Requirements: The Authority's operational priorities or service requirements may change during the contract term. These changes could affect contract usage volumes, scope, or delivery expectations, either positively (increased demand) or negatively (reduced demand). Where such changes occur, the contract may need to be varied to reflect revised requirements.
Applicable trade agreements
- Government Procurement Agreement (GPA)
Conflicts assessment prepared/revised
Yes
Procedure
Procedure type
Competitive flexible procedure
Competitive flexible procedure description
It is the intention of the Authority to follow a two-stage process under this procedure as follows. However, the Authority retains the right to amend the stages if required throughout the process. This includes amending the number of stages or re-running any stage of the process.
Tender Stage 1:
• Publish tender notice and tender documents
• Receive tenders
• Assess tenders to shortlist those to be invited to Stage 2
• Notify shortlisted suppliers and invite to Stage 2
Tender Stage 2:
• Conduct presentations
Award Stage:
• Notify suppliers and issue assessment summaries
• Publish contract award notice and commence standstill
• Award contract
Contracting authority
NHS Blood and Transplant
- Public Procurement Organisation Number: PDBY-6395-VWBP
500 North Bristol Park
Bristol
BS34 7QH
United Kingdom
Email: rowena.thomas@nhsbt.nhs.uk
Website: https://www.nhsbt.nhs.uk/
Region: UKK12 - Bath and North East Somerset, North Somerset and South Gloucestershire
Organisation type: Public authority - central government